Recent Finacing
Recent Raise
Inozyme Pharma develops enzyme replacement therapies, including INZ-701 to restore plasma pyrophosphate (PPi) and prevent pathological calcification in vasculature, kidneys, and bone for ENPP1/ABCC6-related disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Inozyme.
